This randomized controlled trial assessed the effectiveness of hyperbaric oxygen therapy (HBOT) for improving symptoms and cognitive functions in individuals with persistent postconcussion syndrome (PPCS) following mild traumatic brain injury (mTBI). Sixty-three participants were treated with 40 HBOT sessions over eight weeks, showing significant improvements in neurocognitive performance, symptom severity,
